Clinical Considerations Should be used cautiously in patients who have a history of pancreatitis
Baseline Assessment: Glucose body function markers Growth factor levels (IGF-1, IGFBP-3) Liver function tests Complete blood count Body makeup measurements Ongoing Tracking: Blood glucose levels (very important due to insulin-like effects) Signs of hypoglycemia (if applicable to research model) Injection site reactions Research-specific parameters based on study objectives Post-Protocol Assessment: Repeat baseline measurements Assess research outcomes Document any adverse findings Plan appropriate washout period Cycle Length and Off-Cycle Periods Research protocols often incorporate cycle lengths and off-cycle periods to optimize results and minimize possible desensitization
SongXYaoMZhangJHuangBLiXZhangMet al
Medical Adjustments & Physician Input Sometimes, breaking a weight loss plateau means adjusting your medication dose, timing, or adding supportive therapies
Leelarathna L, Evans ML, Neupane S, Rayman G, Lumley S, Cranston I, et al
Other serious hypersensitivity reactions, including anaphylaxis, laryngeal edema, and bronchospasm have been reported following intravenous levocarnitine administration, mostly in patients with end-stage renal disease undergoing dialysis